On the one hand, dysregulation in Ca2+ signaling influences Aβ aggregation and deposition and Tau phosphorylation [18], and in more general terms, incites the longitudinal progression of AD pathology [19]. The gene discussed is MAPT; the disease is Alzheimer disease.